Literature DB >> 1873587

Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy.

D Valteau1, O Hartmann, L Brugieres, G Vassal, E Benhamou, A Andremont, C Kalifa, J Lemerle.   

Abstract

A total of 251 patients were given 326 courses of high-dose chemotherapy followed by autologous bone marrow transplantation between February 1979 and August 1988. Ninety-one cases of septicaemia developed in 84 patients, 33 of these cases (36%) were due to streptococci. The outcome was fatal for four patients (12.1%). No specific risk factors were identified which might account for this septicaemia and no clinical feature was significantly associated with these cases of bacterial infection. Pulmonary and neurologic septic complications, however, were of very poor prognosis since all patients with these complications died. The high rate of streptococcal septicaemia and the poor outcome for patients with prolonged and profound neutropenia led us to modify our choice of initial broad-spectrum antibiotic therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1873587

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

1.  Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.

Authors:  E R Broun; J L Wheat; P H Kneebone; K Sundblad; R A Hromas; G Tricot
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

2.  White pulp reconstitution after human bone marrow transplantation.

Authors:  A Nakayama; N Hirabayashi; M Ito; K Kasai; M Fujino; M Ohbayashi; J Asai
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

3.  Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole.

Authors:  H F Guiot; J W van der Meer; P J van den Broek; R Willemze; R van Furth
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

4.  A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Authors:  W V Kern; B Hay; P Kern; R Marre; R Arnold
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

5.  Changing causes of septicaemia in paediatric oncology patients: effect of imipenem use.

Authors:  J W Gray; S J Pedler; A W Craft; J Kernahan; K P Windebank; A D Pearson
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

6.  Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.

Authors:  P H McWhinney; S Patel; R A Whiley; J M Hardie; S H Gillespie; C C Kibbler
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

7.  Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.

Authors:  H F Guiot; L J Corel; J M Vossen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.